SCHEMBL7540762

SCHEMBL7540762

C=CCNCCCCCCCCCCCCCC

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.55
ALDH1A1 P00352 2/20 0.55
EPHX1 P07099 2/20 0.50
ADH1B P00325 2/20 0.50
ADH1C P00326 2/20 0.50
ADH1A P07327 2/20 0.50
ADH7 P40394 2/20 0.50
ADH4 P08319 1/20 0.50
CNR1 P21554 1/20 0.49
CNR2 P34972 1/20 0.49
KDM1A O60341 3/20 0.48
FAAH O00519 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.45
ZDHHC2 Q9UIJ5 1/20 0.45
S1PR2 O95136 5/20 0.41
S1PR4 O95977 5/20 0.41
S1PR1 P21453 5/20 0.41
S1PR3 Q99500 5/20 0.41
S1PR5 Q9H228 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4552203 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL7534332 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL6067910 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL7540736 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL7539638 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL817870 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL7533182 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL7535052 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL3261321 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C
SCHEMBL7534941 1.00 TSHR (0.55) TSHRALDH1A1EPHX1ADH1BADH1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116622209-B High-strength warp-deformation-resistant flame-retardant PC composite material and application thereof 广东兴盛迪科技有限公司 2024-02-02 CN disclosed
CN-116622209-A High-strength warp-deformation-resistant flame-retardant PC composite material and application thereof 广东兴盛迪科技有限公司 2023-08-22 CN disclosed
CN-104403046-B A kind of polymer emulsified thickener and preparation method thereof 广州星业科技股份有限公司 2017-06-23 CN disclosed
CN-104403046-B A kind of polymer emulsified thickener and preparation method thereof 广州星业科技股份有限公司 2017-06-23 CN disclosed
US-20020091254-A1 Stabilizing and/or lowering the color number of alkenyl compounds BASF AKTIENGESELLSCHAFT (DE) 2002-07-11 US disclosed
US-6384216-B1 CARRYING OUT TWO DISTILLATIONS IN WHICH THE PURIFIED ALKENYL COMPOUNDS OBTAINED FROM GAS PHASE BY CONDENSATION, WHERE THE TIME BETWEEN FIRST DISTILLATION AFTER SYNTHESIS OF ALKENYL COMPOUNDS AND FURTHER DISTILLATION BASF AKTIENGESELLSCHAFT (DE) 2002-05-07 US disclosed
US-20020038059-A1 PURIFICATION OF ALKENYL COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2002-03-28 US disclosed
EP-0013450-B1 LAUNDRY DETERGENT COMPOSITION, METHOD OF MANUFACTURE AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 1983-04-06 EP disclosed
EP-0013450-A1 Laundry detergent composition, method of manufacture and use thereof THE PROCTER & GAMBLE COMPANY (US) 1980-07-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091254-A1 Stabilizing and/or lowering the color number of alkenyl compounds SOD1, NOX4, CAT TSHR 4454/4885ALDH1A1 462/4885EPHX1 3862/4885
US-20020038059-A1 PURIFICATION OF ALKENYL COMPOUNDS TPR, AGPAT5, PCNA TSHR 3704/4885ALDH1A1 1108/4885EPHX1 4250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.